Bio-Thera Solutions, Ltd. (SHA:688177)
China
· Delayed Price · Currency is CNY 21.43
-0.29 (-1.34%)
At close: Apr 25, 2025, 2:57 PM CST
Bio-Thera Solutions Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Operating Revenue | 743.17 | 704.41 | 455.13 | 836.58 | 182.86 | Upgrade
|
| Other Revenue | - | 0.38 | 0 | - | - | Upgrade
|
| Revenue | 743.17 | 704.79 | 455.13 | 836.58 | 182.86 | Upgrade
|
| Revenue Growth (YoY) | 5.44% | 54.85% | -45.60% | 357.49% | 26023.37% | Upgrade
|
| Cost of Revenue | 229.54 | 194.67 | 191.09 | 35.9 | 19.92 | Upgrade
|
| Gross Profit | 513.62 | 510.13 | 264.04 | 800.68 | 162.95 | Upgrade
|
| Selling, General & Admin | 269.62 | 201.3 | 174.24 | 215.45 | 163.47 | Upgrade
|
| Research & Development | 777.63 | 768.64 | 616.39 | 543.42 | 562.65 | Upgrade
|
| Other Operating Expenses | -37.61 | 4.91 | 3.34 | 2.17 | 1.59 | Upgrade
|
| Operating Expenses | 1,010 | 975.04 | 793.26 | 761.93 | 727.82 | Upgrade
|
| Operating Income | -496.02 | -464.91 | -529.22 | 38.75 | -564.87 | Upgrade
|
| Interest Expense | - | -10.38 | -0.06 | -0.78 | -3.7 | Upgrade
|
| Interest & Investment Income | 1.23 | 8.3 | 15.53 | 21.68 | 18.3 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.15 | 1.86 | 1.47 | 0.35 | Upgrade
|
| Other Non Operating Income (Expenses) | -18.79 | -0.33 | -0.26 | -0.39 | -0.47 | Upgrade
|
| EBT Excluding Unusual Items | -513.58 | -467.47 | -512.15 | 60.74 | -550.39 | Upgrade
|
| Gain (Loss) on Sale of Investments | 3.45 | 6.97 | 14.53 | 11.9 | 18.81 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | -0.07 | -0.02 | -0.17 | Upgrade
|
| Asset Writedown | -0.16 | - | - | - | -0.13 | Upgrade
|
| Other Unusual Items | - | 66.09 | 17.29 | 18.42 | 18.67 | Upgrade
|
| Pretax Income | -510.3 | -394.42 | -480.4 | 91.04 | -513.23 | Upgrade
|
| Income Tax Expense | - | 0.11 | 0 | 9.11 | - | Upgrade
|
| Net Income | -510.3 | -394.53 | -480.4 | 81.94 | -513.23 | Upgrade
|
| Net Income to Common | -510.3 | -394.53 | -480.4 | 81.94 | -513.23 | Upgrade
|
| Shares Outstanding (Basic) | 415 | 415 | 414 | 410 | 404 | Upgrade
|
| Shares Outstanding (Diluted) | 415 | 415 | 414 | 410 | 404 | Upgrade
|
| Shares Change (YoY) | -0.10% | 0.28% | 1.09% | 1.38% | 16.97% | Upgrade
|
| EPS (Basic) | -1.23 | -0.95 | -1.16 | 0.20 | -1.27 | Upgrade
|
| EPS (Diluted) | -1.23 | -0.95 | -1.16 | 0.20 | -1.27 | Upgrade
|
| Free Cash Flow | -182.5 | -723.01 | -671.64 | 158.38 | -611.3 | Upgrade
|
| Free Cash Flow Per Share | -0.44 | -1.74 | -1.62 | 0.39 | -1.51 | Upgrade
|
| Gross Margin | 69.11% | 72.38% | 58.01% | 95.71% | 89.11% | Upgrade
|
| Operating Margin | -66.75% | -65.96% | -116.28% | 4.63% | -308.90% | Upgrade
|
| Profit Margin | -68.67% | -55.98% | -105.55% | 9.79% | -280.66% | Upgrade
|
| Free Cash Flow Margin | -24.56% | -102.58% | -147.57% | 18.93% | -334.30% | Upgrade
|
| EBITDA | -409.67 | -384.57 | -448.35 | 108.87 | -505.9 | Upgrade
|
| EBITDA Margin | -55.12% | -54.56% | -98.51% | 13.01% | -276.65% | Upgrade
|
| D&A For EBITDA | 86.36 | 80.34 | 80.88 | 70.12 | 58.98 | Upgrade
|
| EBIT | -496.02 | -464.91 | -529.22 | 38.75 | -564.87 | Upgrade
|
| EBIT Margin | -66.74% | -65.96% | -116.28% | 4.63% | - | Upgrade
|
| Effective Tax Rate | - | - | - | 10.00% | - | Upgrade
|
| Revenue as Reported | - | 704.79 | 455.13 | 836.58 | 184.99 | Upgrade
|
| Advertising Expenses | - | - | - | - | 7.77 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.